NCT01915901 PeptoBismol® Use to Reduce Gastrointestinal Events in Healthy Volunteers Receiving DMF [Tecfidera®] Twice Daily Status COMPLETED Phase PHASE1
NCT01903291 Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS Status COMPLETED Phase N/A
NCT01884935 PK and PD Study of Natalizumab in Pediatric Subjects With RRMS Status COMPLETED Phase PHASE1
NCT01873417 Phase 4 Gastrointestinal Tolerability Study of Dimethyl Fumarate in Patients With Relapsing Forms of Multiple Sclerosis in the United States Status COMPLETED Phase PHASE4
NCT01873404 BG00010 (Neublastin) Phase 2 Multiple Dose Adaptive Design in Participants With Painful Lumbar Radiculopathy Status COMPLETED Phase PHASE2
NCT01864148 Study to Assess the Efficacy, Safety, Tolerability, and Pharmacokinetics of BIIB033 in Participants With Relapsing Forms of Multiple Sclerosis When Used Concurrently With Avonex Status COMPLETED Phase PHASE2
NCT01842126 Phase 1 Subcutaneous Single and Multiple Ascending Dose Study of BG00010 (Neublastin) Status COMPLETED Phase PHASE1
NCT01839656 A Study to Assess the Efficacy, Safety and Pharmacokinetics of Nusinersen (ISIS 396443) in Infants With Spinal Muscular Atrophy (SMA) Status COMPLETED Phase PHASE2
NCT01838668 An Efficacy and Safety Study of BG00012 (Dimethyl Fumarate) in Asian Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) Status COMPLETED Phase PHASE3
NCT01816100 The Effect of Exercise on Strength and Mobility and Corresponding CNS Plasticity in Multiple Sclerosis Patients Status COMPLETED Phase NA
NCT01797965 Long-Term Extension Study in Participants With Multiple Sclerosis Who Have Completed Study 205MS301 (NCT01064401) to Evaluate the Safety and Efficacy of BIIB019 Status TERMINATED Phase PHASE3
NCT01780246 An Open-label Safety and Tolerability Study of Nusinersen (ISIS 396443) in Participants With Spinal Muscular Atrophy Who Previously Participated in ISIS 396443-CS1 (NCT01494701) Status COMPLETED Phase PHASE1
NCT01767493 Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients Status COMPLETED Phase PHASE4
NCT01767311 A Study to Evaluate Safety, Tolerability, and Efficacy of Lecanemab in Subjects With Early Alzheimer's Disease Status COMPLETED Phase PHASE2
NCT01764594 Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus Status COMPLETED Phase PHASE1
NCT01749943 Validation of Hand Held Dynamometer for Assessment of Lower Limb Muscle Strength in Multiple Sclerosis Status COMPLETED Phase N/A
NCT01749098 A Study To Examine The Effects Of PF-04958242 On Ketamine-Induced Cognitive Impairment In Healthy Volunteers Status COMPLETED Phase PHASE1